Chemocentryx Inc (CCXI)

$9.89 0.55 (5.27%)

16:00 EDT CCXI Stock Quote Delayed 30 Minutes

Louis Navellier and the InvestorPlace Research Staff

7 ‘A-Rated’ Aggressive Biotech Stocks to Gamble On

By Louis Navellier and the InvestorPlace Research Staff, Editor, Growth Investor Sep 22, 2020

The pandemic has raised awareness about the value of biotech across the world. In turn, these biotech stocks will benefit down the road.

7 “Perfect 10” Healthcare Stocks to Buy Now

4 Top-Ranked Nasdaq Stocks That Have Doubled This Year

5 Small-Cap ETFs and Stocks Crushing the Russell 2000

More Articles

Volume:

Previous Close -

Market Cap 689.82M

PE Ratio -5.78

EPS -1.71

Volume (Avg. Vol.) 3.02M

Day's Range 9.78 - 10.40

52-Week Range 9.55 - 70.29

Dividend & Yield N/A (N/A)

CCXI Stock Predictions, Articles, and Chemocentryx Inc News

From the Web

Top Buys by Top Brass: EVP, Chief Operating Officer Butt's $120.2K Bet on CCXI

From Market News Video May 12, 2021

A company's own top management tend to have the best inside view into the business, so when company officers make major buys, investors are wise to take notice. Presumably the only reason an insider would take their hard-earned cash and use it to buy stock of their company in the open market, is that they expect to make money — maybe they find the stock very undervalued, or maybe they see exciting progress within the company, or maybe both..

Pick Up This Bargain Even Cheaper Than EVP, Chief Operating Officer Butt Did

From Market News Video May 12, 2021

There's an old saying on Wall Street about insider buying: there are many possible reasons to sell a stock, but only one reason to buy. Back on May 7, ChemoCentryx, Inc.'s EVP, Chief Operating Officer, Tausif Butt, invested $120,240.68 into 10,870 shares of CCXI, for a cost per share of $11.06..

Should ChemoCentryx Be in Your Portfolio?

From StockNews.com May 12, 2021

Biotech and pharmaceutical stocks have come to the forefront due to the pandemic. ChemoCentryx (CCXI) aims to provide therapies to combat cancer, autoimmune diseases, and inflammatory disorders, but is it a buy? Read more to find out.

The Daily Biotech Pulse: FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine For Adolescents, Lilly Strikes R&D Collaboration, Vaccine Stocks Novavax, Inovio Sink On Earnings

From Benzinga May 11, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 10) AbbVie Inc. (NYSE: ABBV) -...